Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1084

Inguinal Hernia Global Clinical Trials Review, Q2, 2011

Inguinal Hernia Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Inguinal Hernia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Inguinal Hernia Global
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Inguinal Hernia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Inguinal Hernia Global Clinical Trials Review, Q2, 2011" provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inguinal Hernia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Inguinal Hernia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Inguinal Hernia 20
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Inguinal Hernia Therapeutics Clinical Trials 25
Prominent Drug Comparison 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Koge Sygehus 27
Clinical Trial Overview of Koge Sygehus 27
Innocoll, Inc. 28
Clinical Trial Overview of Innocoll, Inc. 28
Pacira Pharmaceuticals, Inc. 29
Clinical Trial Overview of Pacira Pharmaceuticals, Inc. 29
Clinical Trial Overview of Top Universities / Institutes / Hospitals 30
Mayo Clinic 30
Clinical Trial Overview of Mayo Clinic 30
Diskapi Teaching and Research Hospital 31
Clinical Trial Overview of Diskapi Teaching and Research Hospital 31
Uppsala University Hospital 32
Clinical Trial Overview of Uppsala University Hospital 32
Capital District Health Authority, Canada 33
Clinical Trial Overview of Capital District Health Authority, Canada 33
Umea University 34
Clinical Trial Overview of Umea University 34
Ghent University Hospital 35
Clinical Trial Overview of Ghent University Hospital 35
Helsinki University Central Hospital 36
Clinical Trial Overview of Helsinki University Central Hospital 36
University Hospital Koge 37
Clinical Trial Overview of University Hospital Koge 37
The Children's Hospital of Philadelphia 38
Clinical Trial Overview of The Children's Hospital of Philadelphia 38
Baylor College of Medicine 39
Clinical Trial Overview of Baylor College of Medicine 39
Children's Hospital Boston 40
Clinical Trial Overview of Children's Hospital Boston 40
The Royal Hobart Hospital 41
Clinical Trial Overview of The Royal Hobart Hospital 41
University of Milan 42
Clinical Trial Overview of University of Milan 42
Goteborg University 43
Clinical Trial Overview of Goteborg University 43
Herlev Hospital 44
Clinical Trial Overview of Herlev Hospital 44
Children's Hospital of Eastern Ontario 45
Clinical Trial Overview of Children's Hospital of Eastern Ontario 45
Kuopio University Hospital 46
Clinical Trial Overview of Kuopio University Hospital 46
Medical University of Vienna 47
Clinical Trial Overview of Medical University of Vienna 47
All India Institute of Medical Sciences 48
Clinical Trial Overview of All India Institute of Medical Sciences 48
University Hospital Inselspital, Berne 49
Clinical Trial Overview of University Hospital Inselspital, Berne 49
Maastricht University Medical Center 50
Clinical Trial Overview of Maastricht University Medical Center 50
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 53




...